Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends higher on AstraZeneca, oil stock boost; Just Eat Takeaway slumps

Wed, 21st Apr 2021 09:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Just Eat Takeaway.com slips as Uber Eats plans German
launch

* UK inflation edges up as COVID-19 price hit begins to ease

* UK home prices jump at fastest rate in six years in
February

* FTSE 100 up 0.6%, FTSE 250 slips 0.1%
(Updates to close)

By Devik Jain and Shashank Nayar

April 21 (Reuters) - London's FTSE 100 rose on Wednesday,
led by gains in AstraZeneca and energy heavyweights BP and Royal
Dutch Shell, while Just Eat Takeaway.com dropped following Uber
Eats' plan to foray into the German market.

Drugmaker AstraZeneca gained 1.7% and was the top
boost to the FTSE 100 after India's Serum Institute said it
would sell AstraZeneca vaccine to private hospitals at
$8/dose.

The blue-chip index rose 0.5%, with oil majors
and adding 1.4% and 1.2% respectively, after
Azerbaijan's energy ministry said BP's oil output was 5.9
million tonnes in the first quarter.

Meanwhile, traders assumed a rise in inflation in March
would have little impact on monetary policy after data showed
British consumer price inflation rose to 0.7% in March, while
prices charged by manufacturers rose by 1.9%, the highest in
nearly two years.

"For the Bank of England ... the fact that inflation is
likely to rise this year while the economic outlook is improving
suggests little imminent need to look at negative interest
rates," said James Smith, an economist at ING.

"The less exciting inflation story for 2022 suggests
policymakers will be in little rush to tighten policy, which we
don't expect to happen before 2023."

The FTSE 100 has gained 6.7% year-to-date on optimism about
a speedy economic recovery from the pandemic-driven recession,
although weighing on sentiment are concerns that central banks
would tighten monetary policy sooner than expected on prospects
of rising inflation.

British house prices rose at the fastest annual rate in more
than six years in February, data showed, pushing construction
and material stocks up 0.8%.

Just Eat Takeaway.com fell 2.7% after a media
report about rival Uber Eats' plan to start a food delivery
service in Germany, one of Just Eats’ most lucrative markets.

Entain gained 2.2% after BetMGM, a U.S. joint
venture with MGM Resorts, said it was targeting net
revenue of $1 billion in 2022.
(Reporting by Devik Jain in Bengaluru; editing by Uttaresh.V
and Elaine Hardcastle)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.